A newborn baby boy was diagnosed with the mixed form of congenital mesoblastic nephroma (CMN) representing both classic and cellular histology features in the renal tumor. Additionally, the patient had skin and bone lesions consistent with multifocal involvement of a generalized infantile fibromatosis (IFS). Both skin and bone lesions were distinctly different from CMN and did not represent metastasis. The primary tumor cell line (MCHMN-1), established from the resected right kidney tumor, had a diploid DNA content. Cytogenetic studies revealed deletion on the long arm of chromosome 3 (q21q24) and duplication on the short arm of chromosome 11 (p15). MCH-MN-1 cells expressed ETV6-NTRK3 gene fusion transcripts, characteristic of cellular and mixed forms of CMNs. The cells had high p21 and low Bax mRNA expression in the reverse transcriptase-polymerase chain reaction (RT-PCR) assay. The high level of proliferative marker (Ki67) mRNA expression correlated well with the pluripotent nature of MCH-MN-1 in tissue culture (cell doubling time = 12.4 h). Our results showed that MCH-MN-1 might be a good model cell line for investigations on mesoblastic nephroma.
BolandeRP, BroughAJ, IzantRJJr.Congenital mesoblastic nephroma of infancy. A report of eight cases and the relationship to Wilms' tumor. Pediatrics1967;40:272–278.
2.
HeidelbergerKP, RitcheyML, DauserRC, McKeeverPE, BeckwithJB. Congenital mesoblastic nephroma metastatic to the brain. Cancer1993;72:2499–2502.
3.
VujanicGM, DelemarreJF, MoeslichanS, Mesoblastic nephroma metastatic to the lungs and heart—another face of this peculiar lesion: case report and review of literature. Pediatr Pathol1993;13:143–153.
4.
SchlesingerAE, RosenfieldNS, CastleVP, JastyR.Congenital mesoblastic nephroma metastatic to the brain: a report of two cases. Pediatr Radiol1995;25:S73–S75.
BolandeRP. Congenital and infantile neoplasia of the kidney. Lancet1974;2:1497–1499.
7.
SpelemanF, van den BergE, DhoogeC, Cytogenetic and molecular analysis of cellular atypical mesoblastic nephroma. Genes Chromosomes Cancer1998;21:265–269.
8.
RubinBP, ChenCJ, MorganTW, Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol1998;153:1451–158.
9.
CinDP, LipcseiG, HermandG, BoniverJ, van den BergheH.Congenital mesoblastic nephroma and trisomy 11. Cancer Genet Cytogenet1998;103:68–70.
10.
LoweryM, IssaB, PysherT, BrothmanA.Cytogenetic findings in a case of congenital mesoblastic nephroma. Cancer Genet Cytogenet1995;84:113–115.
11.
KnezevichSR, GarnettMJ, PysherTJ, BeckwithJB, GrundyPE, SorensenPHB. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res1998;58:5046–5048.
12.
HowellCG, OthersenHB, KiviatNE, NorkoolP, BeckwithJB, D'AngioGJ. Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms' Tumor Study. J Pediatr Surg1982;17:826–831.
13.
ChanKL, ChanKW, LeeCW, SaingH.Preoperative chemotherapy for mesoblastic nephroma. Med Pediatr Oncol1995;24:271–273.
14.
SiracusanoS, BosincuL, OnidaA, Congenital mesoblastic nephroma (CMN) with an unusual immunohistochemical feature. Arch Esp Urol1999;52:299–303.
15.
RamachandranC, SauerteigA, SridharKS, ThurerRJ, KrishanA.MDRI gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. Cancer Chemother Pharmacol1993;31:431–441.
16.
RamachandranC, MelnickSJ, EscalonE, Expression of apoptosis, cell proliferation and drug resistance genes in pediatric Wilms' tumors. Anticancer Res2000;20:3759–3766.
17.
RamachandranC, YouW.Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat1999;54:269–278.
18.
RamachandranC, MelnickSJ. Multidrug resistance in human tumors—molecular diagnosis and clinical significance. Mol Diagn1999;4:81–94.
19.
KnezevichSR, McFaddenDE, TaoW, LimJF, SorensenPHB. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet1998;18:184–187.
20.
RamachandranC, KunikaneH, YouW, KrishanA.Phorbol ester–induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochem Pharmacol1998;56:709–718.
21.
GeranRI, GreenbergNH, MacDonaldMM, SchumacherAM, AbbotBJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep1972; Part 3:1–103.
22.
SchofieldDE, YunisJ, FletcherJA. Chromosome aberrations in mesoblastic nephroma. Am J Pathol1993;143: 714–724.
23.
VarsaEW, McConnellTS, DresslerLG, DuncanM.Atypical congenital mesoblastic nephroma: report of a case with karyotypic and flow cytometric analysis. Arch Pathol Lab Med1989;113:1078–1080.
24.
Gonzalez-CrussiF, Sotelo-AvilaC, KiddJM. Malignant mesenchymal nephroma of infancy: report of a case with pulmonary metastases. Am J Surg Pathol1980;4:185–190.
25.
BeckwithJB, WeeksDA. Congenital mesoblastic nephroma: when should we worry?Arch Pathol Lab Med1974; 110:98–99.
26.
TomilnsonGE, ArgyleJC, VelascoS, NisenPD. Molecular characterization of congenital mesoblastic nephroma and its distinction from Wilms' tumor. Cancer1992;70:2358–2361.
27.
MierauGW, BeckwithJB, WeeksDA. Ultrastructure and histogenesis of the renal tumors of childhood: an overview. Ultrastruct Pathol1987;11:313–333.
28.
RobertsP, LockwoodLR, LewisIJ, BaileyCC, BatcupG, WilliamsJ.Cytogenetic abnormalities in mesoblastic nephroma: a link to Wilms' tumor?Med Pediatr Oncol1993;21:416–420.
29.
SharifahNA, YunK, McLayJ.Insulin-like growth factor II gene expression by congenital mesoblastic nephroma. Diagn Mol Pathol1995;4:279–285.
30.
KanekoY, HommaC, MasekiN, SakuraiM, HataJ-I.Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res1991;51:5937–5942.
31.
MascarelloJT, CajulisTR, KrousHF, CarpenterPM. Presence or absence of trisomy 11 is correlated with histologic subtype in congenital mesoblastic nephroma. Cancer Genet Cytogenet1994;77:50–54.
32.
FisherC.Fibromatosis and fibrosarcoma in infancy and childhood. Eur J Cancer1996;32A:2094–2100.
33.
SchofieldDE, FletcherJA, GrierHE, YunisEJ. Fibrosarcoma in inflants and children: application of new techniques. Am J Surg Pathol1994;18:14–24.
